Brief: Xilio Therapeutics Shares Open 6.3% Below IPO Price In Nasdaq Debut
22/10/2021 16:07
Oct 22 (Reuters) -
* XILIO THERAPEUTICS SHARES OPEN AT $15.00 IN NASDAQ DEBUT
VERSUS
IPO PRICE OF $16.00/SHARE
Further company coverage: XLO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla